Assessment of safety and efficacy of Kabasura Kudineer in mild to moderate COVID-19

INTERVENTION: Intervention1: Kabasura Kudineer along with standard treatment: Kabasura kudineer 60ml twice daily before food for 7 days along with standard treatment Control Intervention1: Standard treatment as per the hospital protocol: Standard treatment as per the hospital protocol CONDITION: Health Condition 1: B972‐ Coronavirus as the cause of diseases classified elsewhere PRIMARY OUTCOME: 1.Time to Negative conversion of SARS CoV‐2 ; 2.Time to symptom resolution ; 3.Reduction in Viral load (0,4,7 days) ; ; Timepoint: 4,7 days SECONDARY OUTCOME: 1. Progression to severe ARDS ; 2. Adverse effects/eventsTimepoint: 7 days INCLUSION CRITERIA: a.COVID‐19 positive patients with mild to moderate disease. b.Males and females aged between 18 and 60 years who are admitted in Chettinad Hospital and Research Institute c.Patients willing to give written informed consent.